Rare diseases
Investigational molecules
Locations
Klara Norra Kyrkogata 26, Stockholms Domkyrkofors, 111 22 Stockholm, Sweden
Rare Thyroid Therapeutics International AB focuses on Monocarboxylate Transporter 8 (MCT8) deficiency, a rare disorder affecting thyroid hormone transport and related neurological development. Its clinical research is centred on patients with this inherited condition, with particular attention to males and young children affected by impaired triiodothyronine (T3) regulation.
The sponsor’s studies reflect a medical interest in the endocrine and neurological consequences of MCT8 deficiency, including the management of abnormal thyroid hormone profiles and the clinical features associated with this rare genetic condition.
Clinical trials registered by this sponsor – none is enrolling right now.
Czechia
The NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
